Day: October 3, 2025

Nucliq Biologics: Empowering Women’s Health with Gutcheck VIVO

At Bounce Health Innovation, we celebrate visionary companies that are reshaping healthcare in bold, transformative ways. One such company is Nucliq Biologics, a Newfoundland-based health tech firm that is pioneering personalized wellness for women through groundbreaking microbiome science.

Nucliq’s latest innovation, Gutcheck VIVO, is the first gut microbiome test designed specifically for women. Developed by a team of women scientists, Gutcheck VIVO offers personalized insights into how a woman’s gut health influences hormonal balance, mood, skin, metabolism, and more. This at-home test provides actionable recommendations to help women optimize their health and well-being.

The launch of Gutcheck VIVO marks a significant milestone for Nucliq Biologics, highlighting their commitment to advancing women’s health through cutting-edge science. By focusing on the unique needs of women, Nucliq is empowering individuals to take control of their health with personalized, science-backed insights.

At Bounce, we are proud to support Nucliq Biologics as they continue to lead the way in integrating microbiome science into women’s health. Their work exemplifies how Atlantic Canadian innovation is shaping the future of personalized medicine, not just in our region, but globally.

For more information on Gutcheck VIVO and to order your test, visit mygutcheck.ca

DischargeHUB: Transforming Patient Transitions with Seamless Discharge Planning

At Bounce Health Innovation, we spotlight trailblazing companies that are reshaping healthcare delivery. One such company is DischargeHUB, a Canadian innovator dedicated to enhancing patient flow and optimizing discharge processes across the healthcare continuum.

DischargeHUB offers a comprehensive solution that streamlines the discharge process for patients transitioning from hospital to home. By integrating care coordination, task management, and communication tools, DischargeHUB ensures that all aspects of a patient’s discharge are efficiently managed. This approach not only accelerates the discharge process but also improves patient outcomes by reducing delays and enhancing the quality of care during the transition period.

In Newfoundland and Labrador, DischargeHUB has partnered with NL Health Services to pilot its platform at the Health Sciences Centre and St. Clare’s Mercy Hospital in St. John’s. This six-month pilot focuses on patients who are medically ready to be discharged but require additional support at home, such as home care services or medical equipment. The goal is to facilitate a “home first” approach, allowing patients to recover in the comfort of their own homes while ensuring they receive the necessary care and support.

The collaboration with NL Health Services aligns with the province’s commitment to improving patient flow and reducing alternative level of care (ALC) days. By optimizing discharge planning, DischargeHUB helps free up hospital beds for patients who require acute care, thereby enhancing the overall efficiency of the healthcare system.

Furthermore, DischargeHUB’s partnership with the CAN Health Network underscores its potential for broader application across Canada. Through this collaboration, DischargeHUB aims to expand its reach and impact, bringing its innovative solutions to healthcare providers nationwide.

At Bounce, we are excited to support DischargeHUB as it continues to lead the way in transforming patient transitions and discharge planning. Their work exemplifies how Canadian innovation is driving improvements in healthcare delivery, ensuring that patients receive timely, coordinated, and compassionate care during one of the most critical phases of their healthcare journey.

For more information on DischargeHUB and their innovative solutions, visit their official website.

Granville Biomedical: Expanding Access to Women’s Health Education Worldwide

At Bounce Health Innovation, we celebrate visionary companies that are reshaping healthcare in bold, transformative ways. One of those success stories is Granville Biomedical, a Newfoundland and Labrador-based company that is breaking new ground in women’s health education—now reaching over 28 countries around the world.

Founded with a clear mission to improve access to high-quality educational tools for women’s health, Granville Biomedical designs anatomically accurate pelvic health models that empower healthcare professionals and patients alike. What began as a small effort to address gaps in clinical training has evolved into a global operation, with their products now used by institutions, educators, and healthcare practitioners worldwide.

Granville Biomedical’s flagship products, including the Venus Diversity Trio and the Iris Pessary & Device Demonstration Model, provide realistic, inclusive representations of anatomy in varying skin tones and for diverse patient populations. These models enable clinicians to practice procedures, demonstrate devices, and educate patients in ways that are both accurate and accessible—helping to destigmatize topics that are often overlooked.

This innovation is making a tangible impact. Healthcare providers from universities to clinics are integrating Granville’s models into training and patient care programs, enhancing clinical confidence and improving patient outcomes. By offering tools that are anatomically precise and culturally inclusive, Granville Biomedical is equipping healthcare professionals with the resources to provide high-quality, equitable care—whether they are in St. John’s, Birmingham, or beyond.

Closer to home, Granville Biomedical is helping to strengthen education and awareness around women’s health across Newfoundland and Labrador. Their success demonstrates the potential of Atlantic Canadian innovation to not only fill local gaps but also influence global healthcare practices.

In 2025, Granville Biomedical celebrated a major milestone: their expansion into 28 countries. This growth reflects both the demand for their high-quality educational tools and the company’s commitment to advancing women’s health on an international scale. It’s a testament to how a local vision can have a worldwide impact.

At Bounce, we’re proud to support Granville Biomedical as they continue to empower healthcare providers, educators, and patients around the globe. Their work is a shining example of how Atlantic Canadian innovation is shaping the future of medicine—not just in our region, but internationally.